Rankings
▼
Calendar
DSGN FY 2025 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DSGN
Design Therapeutics, Inc.
$569M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$79M
Net Income
-$70M
EPS (Diluted)
$-1.22
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$55M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$226M
Total Liabilities
$14M
Stockholders' Equity
$213M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$596,000
+100.0%
Operating Income
-$79M
-$62M
-27.4%
Net Income
-$70M
-$50M
-40.7%
← Q4 2024
All Quarters
Q1 2025 →